Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. 1998

H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
Department of Radiology, Biomedical Imaging Research Center, Fukui Medical School, Japan.

To determine whether PET could help differentiate malignant from benign thyroid tumors, 18F-fluorodeoxyglucose (FDG) accumulation and 201Tl scintigraphy were examined relative to histological diagnosis. METHODS Nodular thyroid lesions in 11 patients were evaluated before surgical resection. Static PET scanning with 370 MBq FDG was done for 20 min (from 40 to 60 min postinjection) in all patients, and standardized uptake values (SUVs) in these lesions were calculated. In addition, eight patients were evaluated with dynamic PET scan up to 60 min postinjection, and the lesions were further evaluated using graphical analysis. Thallium-201 delayed images were visually evaluated in 10 patients. RESULTS Four of 11 nodules were well-differentiated papillary carcinoma, another five were benign follicular adenomas, one was a multinodular goiter and another a case of chronic thyroiditis that was proved not to contain a nodule. Time-activity curves of FDG uptake showed different patterns in malignant and benign tumors. In the malignant tumors, FDG uptake increased with time after the tracer injection. By contrast, FDG uptake in benign tumors gradually decreased. With use of a cutoff value of 5.0 mg/ml for SUV and 10 microl x min(-1) x ml(-1) for Kc (K complex value determined using the linear fitting of the time-activity curve of FDG accumulation), all of the four malignant nodules and the six benign nodules were separated correctly. Chronic thyroiditis had high SUV in the malignant range. Of the four patients with thyroid carcinoma, the delayed 201Tl images revealed a slightly higher or equal uptake to background activity. In a patient with chronic thyroiditis, the delayed 201Tl images revealed diffuse accumulation higher than background activity. CONCLUSIONS FDG-PET is superior to 201Tl in differentiating malignant from benign tumors. Both SUVs and Kc values were useful indexes for this discrimination. Although careful evaluation is needed for chronic inflammatory lesions, this technique appears to be useful in evaluating thyroid nodules.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
March 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
January 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
February 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
June 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
September 1998, European journal of nuclear medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
January 1993, AJNR. American journal of neuroradiology,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
June 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
March 2008, La Radiologia medica,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
September 1996, Journal of the American College of Cardiology,
H Uematsu, and N Sadato, and T Ohtsubo, and T Tsuchida, and S Nakamura, and K Sugimoto, and A Waki, and N Takahashi, and Y Yonekura, and G Tsuda, and H Saito, and N Hayashi, and K Yamamoto, and Y Ishii
February 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!